Skip to main content
Erschienen in: Clinical and Translational Oncology 11/2012

01.11.2012 | Research Article

Predicting the factors of lateral lymph node metastasis in papillary microcarcinoma of the thyroid in eastern China

verfasst von: Rui-chao Zeng, Quan Li, Kuai-lu Lin, Wei Zhang, Er-li Gao, Guan-li Huang, Xiao-hua Zhang, Min-hua Zheng

Erschienen in: Clinical and Translational Oncology | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Lateral lymph node metastasis is common in papillary thyroid microcarcinoma (PTMC). The present study evaluated the clinicopathologic characteristics and ultrasonographic (US) findings in predicting lateral LNM from PTMC in eastern China.

Materials and methods

A total of 176 patients with confirmed PTMC by final histological examination who underwent central lymph node dissection (LND) and lateral LND were enrolled in our study. The clinicopathological and US data from the cases were analyzed retrospectively to determine the independent predictive factors for lateral LNM. Then, a scoring system was developed on the basis of independent factors. The sum of the points for individuals was evaluated for the value in predicting lateral LNM.

Results

Central LNM, underlying Hashimoto’s thyroiditis, upper pole location, no well-defined margin and presence of calcifications were independent predictive factors for lateral LNM on multivariate analysis. Clinicopathological and US index points were statistically significant, with ≤2 favoring lateral LNM negativity with a sensitivity of 83.3 %, positive predictive value of 89.6 % and negative predictive value of 72.9 %.

Conclusions

When the evaluation for lateral lymph nodes from a preoperative approach is inadequate or not obvious, our scoring system for prediction of lateral LNM can be another choice. Patients with clinicopathological and US index points ≤2 could be considered as lateral LNM negative, so more diagnostic approach is recommended for patients with clinicopathological and US index points >2.
Literatur
1.
Zurück zum Zitat Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911PubMedCrossRef Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911PubMedCrossRef
2.
Zurück zum Zitat Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56:531–538PubMedCrossRef Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56:531–538PubMedCrossRef
3.
Zurück zum Zitat Lang W, Borrusch H, Bauer L (1988) Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 90:72–76PubMed Lang W, Borrusch H, Bauer L (1988) Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 90:72–76PubMed
4.
Zurück zum Zitat Xiang J, Wu Y, Li DS, Shen Q, Wang ZY, Sun TQ, An Y, Guan Q (2010) New clinical features of thyroid cancer in eastern China. J Visc Surg 147:e53–e56PubMedCrossRef Xiang J, Wu Y, Li DS, Shen Q, Wang ZY, Sun TQ, An Y, Guan Q (2010) New clinical features of thyroid cancer in eastern China. J Visc Surg 147:e53–e56PubMedCrossRef
5.
Zurück zum Zitat Wang Y, Ji M, Wang W, Miao Z, Hou P, Chen X, Xu F, Zhu G, Sun X, Li Y et al (2008) Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer. Endocr Relat Cancer 15:183–190PubMedCrossRef Wang Y, Ji M, Wang W, Miao Z, Hou P, Chen X, Xu F, Zhu G, Sun X, Li Y et al (2008) Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer. Endocr Relat Cancer 15:183–190PubMedCrossRef
6.
Zurück zum Zitat Patron V, Bedfert C, Le Clech G, Aubry K, Jegoux F (2011) Pattern of lateral neck metastases in N0 papillary thyroid carcinoma. BMC Cancer 11:8PubMedCrossRef Patron V, Bedfert C, Le Clech G, Aubry K, Jegoux F (2011) Pattern of lateral neck metastases in N0 papillary thyroid carcinoma. BMC Cancer 11:8PubMedCrossRef
7.
Zurück zum Zitat Kutler DI, Crummey AD, Kuhel WI (2011) Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma. Head Neck 34:260–263PubMedCrossRef Kutler DI, Crummey AD, Kuhel WI (2011) Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma. Head Neck 34:260–263PubMedCrossRef
8.
Zurück zum Zitat Sadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–703 (discussion 703–695)PubMedCrossRef Sadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–703 (discussion 703–695)PubMedCrossRef
9.
Zurück zum Zitat Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW et al (1998) Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012–1021PubMedCrossRef Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW et al (1998) Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012–1021PubMedCrossRef
10.
Zurück zum Zitat Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79:564–573PubMedCrossRef Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79:564–573PubMedCrossRef
11.
Zurück zum Zitat Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31:2085–2091PubMedCrossRef Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31:2085–2091PubMedCrossRef
12.
Zurück zum Zitat Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133:276–280PubMedCrossRef Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133:276–280PubMedCrossRef
13.
Zurück zum Zitat Ortiz S, Rodriguez JM, Soria T, Perez-Flores D, Pinero A, Moreno J, Parrilla P (2001) Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg 124:261–265PubMedCrossRef Ortiz S, Rodriguez JM, Soria T, Perez-Flores D, Pinero A, Moreno J, Parrilla P (2001) Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg 124:261–265PubMedCrossRef
14.
Zurück zum Zitat Chung YS, Kim JY, Bae JS, Song BJ, Kim JS, Jeon HM, Jeong SS, Kim EK, Park WC (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid 19:241–246PubMedCrossRef Chung YS, Kim JY, Bae JS, Song BJ, Kim JS, Jeon HM, Jeong SS, Kim EK, Park WC (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid 19:241–246PubMedCrossRef
15.
Zurück zum Zitat Kim TY, Hong SJ, Kim JM, Gu Kim W, Gong G, Ryu JS, Kim WB, Yun SC, Shong YK (2008) Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296PubMedCrossRef Kim TY, Hong SJ, Kim JM, Gu Kim W, Gong G, Ryu JS, Kim WB, Yun SC, Shong YK (2008) Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296PubMedCrossRef
16.
Zurück zum Zitat Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMed Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMed
17.
Zurück zum Zitat Kwak JY, Kim EK, Kim MJ, Son EJ, Chung WY, Park CS, Nam KH (2009) Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann Surg Oncol 16:1348–1355PubMedCrossRef Kwak JY, Kim EK, Kim MJ, Son EJ, Chung WY, Park CS, Nam KH (2009) Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann Surg Oncol 16:1348–1355PubMedCrossRef
18.
Zurück zum Zitat Lim YS, Lee JC, Lee YS, Lee BJ, Wang SG, Son SM, Kim IJ (2011) Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. Surgery 150:116–121PubMedCrossRef Lim YS, Lee JC, Lee YS, Lee BJ, Wang SG, Son SM, Kim IJ (2011) Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. Surgery 150:116–121PubMedCrossRef
19.
Zurück zum Zitat Lee KJ, Cho YJ, Kim SJ, Lee SC, Kim JG, Ahn CJ, Lee DH (2011) Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg 35:318–323PubMedCrossRef Lee KJ, Cho YJ, Kim SJ, Lee SC, Kim JG, Ahn CJ, Lee DH (2011) Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg 35:318–323PubMedCrossRef
20.
Zurück zum Zitat Kim SS, Lee BJ, Lee JC, Kim SJ, Jeon YK, Kim MR, Huh JE, Mok JY, Kim BH, Kim YK, Kim IJ (2011) Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis. Head Neck 33:1272–1277PubMedCrossRef Kim SS, Lee BJ, Lee JC, Kim SJ, Jeon YK, Kim MR, Huh JE, Mok JY, Kim BH, Kim YK, Kim IJ (2011) Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis. Head Neck 33:1272–1277PubMedCrossRef
21.
Zurück zum Zitat Kim HS, Choi YJ, Yun JS (2010) Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 21:149–153PubMedCrossRef Kim HS, Choi YJ, Yun JS (2010) Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 21:149–153PubMedCrossRef
22.
Zurück zum Zitat Lin K-L, Wang O-C, Zhang X-H, Dai X–X, Hu X-Q, Qu J-M (2010) The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma. Ann Surg Oncol 17:3294–3300PubMedCrossRef Lin K-L, Wang O-C, Zhang X-H, Dai X–X, Hu X-Q, Qu J-M (2010) The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma. Ann Surg Oncol 17:3294–3300PubMedCrossRef
23.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121PubMedCrossRef Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121PubMedCrossRef
24.
Zurück zum Zitat Kim SS, Lee B-J, Lee J-C, Kim S-J, Lee SH, Jeon YK, Kim BH, Kim Y-K, Kim I-J (2011) Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck 33:1719–1726PubMedCrossRef Kim SS, Lee B-J, Lee J-C, Kim S-J, Lee SH, Jeon YK, Kim BH, Kim Y-K, Kim I-J (2011) Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck 33:1719–1726PubMedCrossRef
25.
Zurück zum Zitat Ito Y, Kobayashi K, Tomoda C, Uruno T, Takamura Y, Miya A, Matsuzuka F, Kuma K, Miyauchi A (2005) Ill-defined Edge on Ultrasonographic Examination Can Be a Marker of Aggressive Characteristic of Papillary Thyroid Microcarcinoma. World J Surg 29:1007–1011PubMedCrossRef Ito Y, Kobayashi K, Tomoda C, Uruno T, Takamura Y, Miya A, Matsuzuka F, Kuma K, Miyauchi A (2005) Ill-defined Edge on Ultrasonographic Examination Can Be a Marker of Aggressive Characteristic of Papillary Thyroid Microcarcinoma. World J Surg 29:1007–1011PubMedCrossRef
26.
Zurück zum Zitat Jun P, Chow LC, Jeffrey RB (2005) The sonographic features of papillary thyroid carcinomas: pictorial essay. Ultrasound Q 21:39–45PubMed Jun P, Chow LC, Jeffrey RB (2005) The sonographic features of papillary thyroid carcinomas: pictorial essay. Ultrasound Q 21:39–45PubMed
27.
Zurück zum Zitat Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A, Tomoda C, Ito Y, Uruno T (2004) Preoperative Ultrasonographic Examination for Lymph Node Metastasis: usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid. World J Surg 28:498–501PubMedCrossRef Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A, Tomoda C, Ito Y, Uruno T (2004) Preoperative Ultrasonographic Examination for Lymph Node Metastasis: usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid. World J Surg 28:498–501PubMedCrossRef
28.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30:91–99PubMedCrossRef Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30:91–99PubMedCrossRef
29.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920PubMedCrossRef Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920PubMedCrossRef
30.
Zurück zum Zitat Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG (2008) Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 18:411–418PubMedCrossRef Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG (2008) Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 18:411–418PubMedCrossRef
31.
Zurück zum Zitat Koike E, Noguchi S, Yamashita H, Murakami T, Ohshima A, Kawamoto H (2001) Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 136:334–337PubMedCrossRef Koike E, Noguchi S, Yamashita H, Murakami T, Ohshima A, Kawamoto H (2001) Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 136:334–337PubMedCrossRef
Metadaten
Titel
Predicting the factors of lateral lymph node metastasis in papillary microcarcinoma of the thyroid in eastern China
verfasst von
Rui-chao Zeng
Quan Li
Kuai-lu Lin
Wei Zhang
Er-li Gao
Guan-li Huang
Xiao-hua Zhang
Min-hua Zheng
Publikationsdatum
01.11.2012
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 11/2012
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0875-2

Weitere Artikel der Ausgabe 11/2012

Clinical and Translational Oncology 11/2012 Zur Ausgabe

Educational Series - Blue Series

miRNAs as biomarkers in prostate cancer

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.